These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24403821)

  • 21. Sustained release of amoxicillin from ethyl cellulose-coated amoxicillin/chitosan-cyclodextrin-based tablets.
    Songsurang K; Pakdeebumrung J; Praphairaksit N; Muangsin N
    AAPS PharmSciTech; 2011 Mar; 12(1):35-45. PubMed ID: 21161458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets.
    Khunawattanakul W; Puttipipatkhachorn S; Rades T; Pongjanyakul T
    Int J Pharm; 2011 Apr; 407(1-2):132-41. PubMed ID: 21291977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucoadhesive tablets for controlled release of acyclovir.
    Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
    Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In brief: effervescent alendronate.
    Med Lett Drugs Ther; 2012 Oct; 54(1401):84. PubMed ID: 23059422
    [No Abstract]   [Full Text] [Related]  

  • 25. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
    Xu X; Gupta A; Sayeed VA; Khan MA
    J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [FOSAVANCE -- alendronate plus vitamin D in a weekly tablet].
    Praxis (Bern 1994); 2006 Jul; 95(27-28):2 p following 1084. PubMed ID: 16888927
    [No Abstract]   [Full Text] [Related]  

  • 27. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA; El-Bagory I; Bayomi MA
    Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of chitosan--polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps.
    Tuntikulwattana S; Sinchaipanid N; Ketjinda W; Williams DB; Mitrevej A
    Drug Dev Ind Pharm; 2011 Aug; 37(8):926-33. PubMed ID: 21417602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of salt form and molecular weight of chitosan on swelling and drug release from chitosan matrix tablets.
    Huanbutta K; Cheewatanakornkool K; Terada K; Nunthanid J; Sriamornsak P
    Carbohydr Polym; 2013 Aug; 97(1):26-33. PubMed ID: 23769512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets.
    Omwancha W; Kouba C; Yelamanchili S; Neau SH
    Drug Dev Ind Pharm; 2011 Aug; 37(8):945-53. PubMed ID: 21417614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
    Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
    Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of gastroretentive floating tablets of Silymarin.
    Garg R; Gupta GD
    Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyethyl cellulose hydrogel for wound dressing: Fabrication, characterization and in vitro evaluation.
    El Fawal GF; Abu-Serie MM; Hassan MA; Elnouby MS
    Int J Biol Macromol; 2018 May; 111():649-659. PubMed ID: 29339283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which water for alendronate administration?
    Pellegrini R
    Osteoporos Int; 2009 Aug; 20(8):1451. PubMed ID: 18958383
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Different Polymer Concentration on Drug Release Rate and Physicochemical Properties of Mucoadhesive Gastroretentive Tablets.
    Agarwal S; Murthy RS
    Indian J Pharm Sci; 2015; 77(6):705-14. PubMed ID: 26997698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.
    Lamprecht G
    J Pharm Sci; 2009 Oct; 98(10):3575-81. PubMed ID: 19630066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems.
    Diós P; Pernecker T; Nagy S; Pál S; Dévay A
    Saudi Pharm J; 2015 Nov; 23(6):658-66. PubMed ID: 26702261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Optimization of Methscopolamine Bromide Gastroretentive Floating Tablets Using 32 Factorial Design.
    Singh MP; Kumar M; Shankar R
    Drug Res (Stuttg); 2020 Dec; 70(12):576-582. PubMed ID: 32992345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.